Gene · 4940
Papers2,054
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,054
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-nucleus RNA sequencing and deep tissue proteomics reveal distinct tumour microenvironment in stage-I and II cervical cancer. | J Exp Clin Cancer Res | 2023 | 36683048 | PubTator, text mining | PubMed |
| Host Genetic Variants Linked to COVID-19 Neurological Complications and Susceptibility in Young Adults-A Preliminary Analysis. | J Pers Med | 2023 | 36675784 | PubTator, text mining | PubMed |
| Antimicrobial and Virucidal Potential of Morpholinium-Based Ionic Liquids. | Int J Mol Sci | 2023 | 36675201 | PubTator, text mining | PubMed |
| Adaptive Evolution of the OAS Gene Family Provides New Insights into the Antiviral Ability of Laurasiatherian Mammals. | Animals (Basel) | 2023 | 36670749 | PubTator, text mining | PubMed |
| Cancer Cells Enter an Adaptive Persistence to Survive Radiotherapy and Repopulate Tumor. | Adv Sci (Weinh) | 2023 | 36658726 | PubTator, text mining | PubMed |
| Mucosal Gene Expression in Response to SARS-CoV-2 Is Associated with Viral Load. | J Virol | 2023 | 36656015 | PubTator, text mining | PubMed |
| Integrative Bioinformatics Analysis Identifies DDX60 as a Potential Biomarker for Systemic Lupus Erythematosus. | Dis Markers | 2023 | 36655136 | PubTator, text mining | PubMed |
| Predicting brain-regional gene regulatory networks from multi-omics for Alzheimer's disease phenotypes and Covid-19 severity. | Hum Mol Genet | 2023 | 36648426 | PubTator, text mining | PubMed |
| The race to understand immunopathology in COVID-19: Perspectives on the impact of quantitative approaches to understand within-host interactions. | Immunoinformatics (Amst) | 2023 | 36643886 | PubTator, text mining | PubMed |
| Screening and verification of genes related to polycystic ovary syndrome. | J Int Med Res | 2023 | 36628439 | PubTator, text mining | PubMed |
| Transcriptomic response and immunological responses to chimpanzee adenovirus- and MVA viral-vectored vaccines for RSV in healthy adults. | Clin Exp Immunol | 2023 | 36622786 | PubTator, text mining | PubMed |
| American-Asian- and African lineages of Zika virus induce differential pro-inflammatory and Interleukin 27-dependent antiviral responses in human monocytes. | Virus Res | 2023 | 36610657 | PubTator, text mining | PubMed |
| IFI44L as a novel epigenetic silencing tumor suppressor promotes apoptosis through JAK/STAT1 pathway during lung carcinogenesis. | Environ Pollut | 2023 | 36584854 | PubTator, text mining | PubMed |
| Downregulation of LRP/LR with siRNA inhibits several cancer hallmarks in lung cancer cells. | FEBS Open Bio | 2023 | 36579897 | PubTator, text mining | PubMed |
| Identification of Potential Biomarkers Using Integrative Approach: A Case Study of ESCC. | SN Comput Sci | 2023 | 36573207 | PubTator, text mining | PubMed |
| Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children. | Science | 2023 | 36538032 | Swiss-Prot, curated | PubMed |
| SETDB1: A perspective into immune cell function and cancer immunotherapy. | Immunology | 2023 | 36524435 | PubTator, text mining | PubMed |
| Specific mechanisms of translation initiation in higher eukaryotes: the eIF4G2 story. | RNA | 2023 | 36517212 | PubTator, text mining | PubMed |
| Altered and allele-specific open chromatin landscape reveals epigenetic and genetic regulators of innate immunity in COVID-19. | Cell Genom | 2023 | 36474914 | PubTator, text mining | PubMed |
| Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrier. | Antiviral Res | 2023 | 36423831 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4940/papers?page=18